[Immunosuppression during clinical and experimental organ transplantation].
D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000961:Antilymphocyte Serum; D001769:Blood / Q000528:radiation effects; D004322:Drainage; D004562:Electrocardiography; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D007970:Leukopenia / Q000276:immunology; D016031:Liver Transplantation; D016040:Lung Transplantation; D008214:Lymphocytes / Q000528:radiation effects; D016035:Pancreas Transplantation; D011687:Purines / Q000037:antagonists & inhibitors; D013897:Thoracic Duct / Q000601:surgery; D014181:Transplantation Immunology; D014498:Uracil; D014747:Vinblastine / Q000627:therapeutic use
D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000961:Antilymphocyte Serum; D005493:Folic Acid Antagonists; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011687:Purines; D014498:Uracil; D014747:Vinblastine
Immunosuppression bei klinischer und experimenteller Organtransplantation.